Search Results - "Zuckerman, J.N."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Review: hepatitis B immune globulin for prevention of hepatitis B infection by Zuckerman, J.N.

    Published in Journal of medical virology (01-07-2007)
    “…Specific hepatitis B immune globulin (HBIG) contains a high titer of antibody to hepatitis B surface antigens and provides immediate passive protection against…”
    Get full text
    Journal Article
  2. 2

    Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04 by Boland, G., Beran, J., Lievens, M., Sasadeusz, J., Dentico, P., Nothdurft, H., Zuckerman, J.N., Genton, B., Steffen, R., Loutan, L., Hattum, J. Van, Stoffel, M.

    Published in Vaccine (02-12-2004)
    “…The reactogenicity and safety of an experimental hepatitis B (HB) vaccine containing adjuvant system (AS04) was compared with a licensed vaccine in a phase…”
    Get full text
    Journal Article
  3. 3

    A new accelerated vaccination schedule for rapid protection against hepatitis A and B by Nothdurft, H.D, Dietrich, M, Zuckerman, J.N, Knobloch, J, Kern, P, Vollmar, J, Sänger, R

    Published in Vaccine (15-01-2002)
    “…Background: Increasing travel stresses the requirement for rapid protection against infections such as hepatitis A and B. Methods: This randomised, multicentre…”
    Get full text
    Journal Article
  4. 4

    Current Topics in Hepatitis B by Zuckerman, J.N., Zuckerman, A.J.

    Published in The Journal of infection (01-09-2000)
    “…Over two billion people around the world have been infected with hepatitis B virus, of whom over 350 million are chronic carriers. Some 25% of carriers develop…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine by McDermott, A.B, Cohen, S.B.A, Zuckerman, J.N, Madrigal, J.A

    Published in Vaccine (28-01-1999)
    “…In this study we investigated the effects of a single pre-S/S (Hepagene®) revaccination in a large population of multiple `S' vaccinated anti-HBs antibody…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The influence of host factors and immunogenetics on lymphocyte responses to Hepagene ® vaccination by McDermott, A.B, Madrigal, J.A, Sabin, C.A, Zuckerman, J.N, Cohen, S.B.A

    Published in Vaccine (17-03-1999)
    “…We have shown that both demographic and immunogenetic factors are involved in the immune responses of Hepagene® vaccinated individuals who were persistent…”
    Get full text
    Journal Article
  9. 9

    Pre-travel preparation and outcome of HIV-infected travellers from a UK clinic by Cathcart, S, Boyle, J, Sabin, C, Johnson, M, Zuckerman, J.N

    Published in Travel medicine and infectious disease (01-05-2003)
    “…Objectives. To review the pre-travel preparations and travel health outcomes of HIV-infected individuals. Methods. A prospective questionnaire-based study…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13